An analysis of FDA-approved drugs for psychiatric disorders

被引：15
|
作者：
Kinch, Michael S. [1 ,2 ]
Patridge, Eric [2 ]
机构：
[1] Washington Univ, St Louis, MO 63130 USA
[2] Yale Ctr Mol Discovery, West Haven, CT 06516 USA
来源：
DRUG DISCOVERY TODAY | 2015年 / 20卷 / 03期
关键词：
BIAS;
D O I：
10.1016/j.drudis.2014.08.013
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：292 / 295
页数：4
相关论文
共 50 条
  • [21] Public misconceptions about FDA-approved drugs
    Reactions Weekly, 2011, 1372 (1) : 3 - 3
  • [22] FDA-approved drugs in 2022: A brief outline
    Al-Madhagi, Haitham Ahmed
    SAUDI PHARMACEUTICAL JOURNAL, 2023, 31 (03) : 401 - 409
  • [23] Small-molecule kinase inhibitors: an analysis of FDA-approved drugs
    Wu, Peng
    Nielsen, Thomas E.
    Clausen, Mads H.
    DRUG DISCOVERY TODAY, 2016, 21 (01) : 5 - 10
  • [24] Analysis of FDA-approved imaging agents
    Kinch, Michael S.
    Woodard, Pamela K.
    DRUG DISCOVERY TODAY, 2017, 22 (07) : 1077 - 1083
  • [25] Pharmacogenomic characterization of US FDA-approved cytotoxic drugs
    Peters, Eric J.
    Motsinger-Reif, Alison
    Havener, Tammy M.
    Everitt, Lorraine
    Hardison, Nicholas E.
    Watson, Venita G.
    Wagner, Michael
    Richards, Kristy L.
    Province, Mike A.
    McLeod, Howard L.
    PHARMACOGENOMICS, 2011, 12 (10) : 1407 - 1415
  • [26] Repurposing FDA-approved drugs as potential PARP inhibitors
    Eznarriaga, Maria
    Rahman, Taufiq
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (11) : 2516 - 2516
  • [27] Screening of FDA-Approved Drugs for Treatment of Emerging Pathogens
    Sisk, Jeanne M.
    Frieman, Matthew B.
    ACS INFECTIOUS DISEASES, 2015, 1 (09): : 401 - 402
  • [28] RNA as an off-target for FDA-approved drugs
    Fullenkamp, Christopher R.
    Schneekloth, John S.
    NATURE CHEMISTRY, 2023, 15 (10) : 1329 - 1331
  • [29] Pharmacogenetic Labeling of FDA-Approved Drugs A Regulatory Retrospective
    Drozda, Katarzyna
    Pacanowski, Michael A.
    Grimstein, Christian
    Zineh, Issam
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2018, 3 (04): : 545 - 549
  • [30] Preapproval Promises to Voluntarily Withdraw FDA-Approved Drugs
    Lynch, Holly Fernandez
    Sachs, Rachel E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (24): : 2392 - 2393
12345